Back to search
FDAFDA · Food and drugs·Recall number Z-0266-2023

InControl Insulin Syringes, Short Needle, 29 Gauge, 1CC

Published November 30, 2022 · Recall initiated: January 19, 2018

Summary

FDA records medical device Class II recall Z-0266-2023, published November 30, 2022 and initiated January 19, 2018. Recalling firm: Allison Medical, Inc.; Status: Completed; Reported quantity: 1,500 Boxes (150,000 syringes); Lot: UDI/Lot/Expiration: 00041220791484/ 170407/ 2022-03-31. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Insulin syringe retail packages incorrectly labeled as "Short Needle".

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Allison Medical, Inc.
Distributor
Texas
Lot
UDI/Lot/Expiration: 00041220791484/ 170407/ 2022-03-31
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was InControl Insulin Syringes, Short Needle, 29 Gauge, 1CC recalled?

Yes. FDA published recall Z-0266-2023 on November 30, 2022. Reported hazard: Insulin syringe retail packages incorrectly labeled as "Short Needle".

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail